Skip to main content

Table 2 Prevalence of AMA1 antibodies seropositivity in children who never received SMC and children that SMC for 1, 2 and 3 years

From: Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali

 

n

%

95% CI

Unadjusted

Adjusteda

OR

95% CI

p

OR

95% CI

p

No SMC

154

97.5

95.0–99.9

Ref

–

–

Ref

–

–

SMC 1Y

263

97.0

95.1–99.1

0.85

0.25–2.88

0.79

1.18

0.34–4.07

0.79

SMC 2Y

226

97.4

95.4–99.5

0.97

0.27–3.52

0.97

1.45

0.39–5.37

0.58

SMC 3Y

218

94.4

91.4–97.4

0.43

0.13–1.36

0.15

0.66

0.21–2.15

0.49

SMC 1–3Y

707

96.3

94.9–97.6

0.68

0.23–1.97

0.47

0.99

0.33–2.97

0.99

  1. SMC 1Y received SMC for 1 year, SMC 2Y received SMC for 2 years, SMC 3Y received SMC for 3 years, SMC 1–3Y received SMC for 1, 2, or 3 years
  2. aAdjusted for age, gender and malaria infection
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us